| CHINA-GUANGZHOU-INMODE-MEDICAL-TECHNOLOGY-LTD |
CHINA-GUANGZHOU-INMODE-MEDICAL-TECHNOLOGY-LTD |
85%
|
y. • Latin America : We plan to strengthen our network of exclusive distributors in all countries in Latin America. • Asia-Pacific : In addition to our direct sales presence in India, Australia and J… |
| ISRAEL-LTD |
ISRAEL-LTD |
85%
|
Outside the United States or Canada, the product is sent to our distributors or our facility in Israel. Either we or our distributors quickly repair the product and ship it back to the customer. We h… |
| OPTIMAS-OPTIMASMAX-VOTIVA-DEFINE-CO |
OPTIMAS-OPTIMASMAX-VOTIVA-DEFINE-CO |
85%
|
. • Controlled continuous RF heating. We believe our controlled continuous RF technology is the first auto-adjusting non-invasive thermal skin treating technology for deep and uniform tissue stimulat… |
| APYX |
Apyx Medical Corporation |
72%
|
Reciprocal relationship from APYX graph: Reciprocal relationship from INMD graph: sociated with our products are protected by U.S. copyright law. We also filed for protection available under trademar… |
| APYX |
Apyx Medical Corporation |
72%
|
sociated with our products are protected by U.S. copyright law. We also filed for protection available under trademark law. As of December 31, 2024, we own 16 registered trademarks in the United Stat… |
| SBC |
SBC Medical Group Holdings Incorporated |
72%
|
Reciprocal relationship from SBC graph: Reciprocal relationship from INMD graph: Reciprocal relationship from SBC graph: Reciprocal relationship from INMD graph: Reciprocal relationship from SBC grap… |
| SBCWW |
SBCWW |
72%
|
Reciprocal relationship from SBCWW graph: eline of top-tier development opportunities. Upon selecting a new market, we typically manage the opening of one or two clinics to prove concept viability in… |
| ABBVIE-CUTERA-INC-APYX-MEDICAL-CORPORATION-VENUS |
ABBVIE-CUTERA-INC-APYX-MEDICAL-CORPORATION-VENUS |
62%
|
sociated with our products are protected by U.S. copyright law. We also filed for protection available under trademark law. As of December 31, 2024, we own 16 registered trademarks in the United Stat… |
| ABBVIE-INC-APYX-MEDICAL-CORPORATION-VENUS-CONCEP |
ABBVIE-INC-APYX-MEDICAL-CORPORATION-VENUS-CONCEP |
62%
|
ding AbbVie Inc., Apyx Medical Corporation, Venus Concept Inc., BTL Aesthetics, Inc. and Sisram Medical Ltd, as well as by private companies, such as Cutera, Inc., Cynosure LLC, Lumenis Ltd., and Can… |
| BTL-AESTHETICS-INC |
BTL-AESTHETICS-INC |
62%
|
ding AbbVie Inc., Apyx Medical Corporation, Venus Concept Inc., BTL Aesthetics, Inc. and Sisram Medical Ltd, as well as by private companies, such as Cutera, Inc., Cynosure LLC, Lumenis Ltd., and Can… |
| BTL-INDUSTRIES-LTD |
BTL-INDUSTRIES-LTD |
62%
|
of 43 research and development staff based mainly in Israel. Our research and development efforts are focused on the development of new products, as well as on the extension of our existing products … |
| CANDELA-MEDICAL-INC |
CANDELA-MEDICAL-INC |
62%
|
sociated with our products are protected by U.S. copyright law. We also filed for protection available under trademark law. As of December 31, 2024, we own 16 registered trademarks in the United Stat… |
| CUTERA-INC-CYNOSURE-LLC-LUMENIS-LTD |
CUTERA-INC-CYNOSURE-LLC-LUMENIS-LTD |
62%
|
ding AbbVie Inc., Apyx Medical Corporation, Venus Concept Inc., BTL Aesthetics, Inc. and Sisram Medical Ltd, as well as by private companies, such as Cutera, Inc., Cynosure LLC, Lumenis Ltd., and Can… |
| CYNOSURE-LLC-LUMENIS-LTD |
CYNOSURE-LLC-LUMENIS-LTD |
62%
|
Cynosure LLC, Lumenis Ltd., and Candela Medical Inc. Competition with these companies could result in reduced prices and profit margins and loss of market share, any of which could harm our business,… |
| CYNOSURE-LLC-LUTRONIC-LUMENIS-LTD-BTL-AESTHETICS |
CYNOSURE-LLC-LUTRONIC-LUMENIS-LTD-BTL-AESTHETICS |
62%
|
sociated with our products are protected by U.S. copyright law. We also filed for protection available under trademark law. As of December 31, 2024, we own 16 registered trademarks in the United Stat… |
| FIRST-ROBOTICS-GROUP |
FIRST-ROBOTICS-GROUP |
62%
|
ncorporated by reference into and should not be considered a part of this Annual Report on Form 20-F, and the reference to our website in this Annual Report on Form 20-F is an inactive textual refere… |
| GUANGZHOU-INMODE-MEDICAL-TECHNOLOGY-LTD |
GUANGZHOU-INMODE-MEDICAL-TECHNOLOGY-LTD |
62%
|
ncorporated by reference into and should not be considered a part of this Annual Report on Form 20-F, and the reference to our website in this Annual Report on Form 20-F is an inactive textual refere… |
| INMODE-MEDICAL-TECHNOLOGY-LTD |
INMODE-MEDICAL-TECHNOLOGY-LTD |
62%
|
gzhou InMode Medical Technology Ltd., as well as enhance our network of exclusive distributors in other countries in Asia. • Continue to further penetrate our existing customer base and drive recurri… |
| INVASIX-UK-LTD |
INVASIX-UK-LTD |
62%
|
ncorporated by reference into and should not be considered a part of this Annual Report on Form 20-F, and the reference to our website in this Annual Report on Form 20-F is an inactive textual refere… |
| MEDICAL-TECHNOLOGY-LTD |
MEDICAL-TECHNOLOGY-LTD |
62%
|
de Medical Technology Ltd., as well as enhance our network of exclusive distributors in all other countries in Asia. • Continue to further penetrate our existing customer base and drive recurring rev… |
| MERZ-PHARMA-GROUP |
MERZ-PHARMA-GROUP |
62%
|
sociated with our products are protected by U.S. copyright law. We also filed for protection available under trademark law. As of December 31, 2024, we own 16 registered trademarks in the United Stat… |
| NON-INVASIVE-MEDICAL-AESTHETIC-TECHNOLOGIES |
NON-INVASIVE-MEDICAL-AESTHETIC-TECHNOLOGIES |
62%
|
that we believe will provide patients with a medical treatment solution for snoring and rhinitis. The handpiece for treatment of turbinates is based on our Deep Subdermal Fractional RF technology and… |
| SISRAM-MEDICAL-LTD |
SISRAM-MEDICAL-LTD |
62%
|
sociated with our products are protected by U.S. copyright law. We also filed for protection available under trademark law. As of December 31, 2024, we own 16 registered trademarks in the United Stat… |
| SYNERON-MEDICAL-LTD |
SYNERON-MEDICAL-LTD |
62%
|
. Our management team has significant expertise in the medical aesthetics industry with a proven track record of successfully developing and commercializing innovative technologies. Moshe Mizrahy and… |
| VALEANT-PHARMACEUTICALS-INTERNATIONAL-INC |
VALEANT-PHARMACEUTICALS-INTERNATIONAL-INC |
62%
|
sociated with our products are protected by U.S. copyright law. We also filed for protection available under trademark law. As of December 31, 2024, we own 16 registered trademarks in the United Stat… |
